Company / Profit Margin
Processa Pharmaceuticals, Inc. Profit Margin History
FY2013-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-2957.2%
FY2016
5-year range
-4220.7% / -982.0%
FY2013-FY2016
Trend
+29.9%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -982.0% to -2957.2% over the past 2 years.
Based on SEC 10-K filings.
-2957.2% in FY2016 with a 3-year CAGR of -1687.1%.
Declined from -982.0% to -2957.2% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -1687.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, profit margin increased 29.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | - | - |
| FY2016 | -2957.2% | +29.9% |
| FY2015 | -4220.7% | -329.8% |
| FY2014 | -982.0% | +22.7% |
| FY2013 | -1270.1% | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026